SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 24.23 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 11.24 |
| Book Value / Share | 0.97 |
| Price / Book | n/a |
| NCAV ($M) | 8.97 |
| NCAV / Share | 0.78 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.35 |
| Return on Assets (ROA) | -0.30 |
| Return on Equity (ROE) | -0.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.14 |
| Current Ratio | 14.08 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 10.10 |
| Assets | 12.37 |
| Liabilities | 1.12 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.51 |
| Operating Income | -3.84 |
| Net Income | -4.13 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -3.43 |
| Cash from Investing | -2.83 |
| Cash from Financing | 10.92 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Choo Chee Kong | 40.30 | 0.00 | |
| 13G | Zeng Jieming | 5.11 | 0.00 | |
| 13G | mDR Ltd | 11.59 | 0.00 | |
| 13G | Wang Shu | 7.66 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 920 | 7,691 | 11.96 | |
| 610 | 5,705 | 10.69 | |
| 30 | 635 | 4.72 | |
| 5,401 | 54,985 | 9.82 | |
| 133 | 756 | 17.59 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FTLF – FitLife Brands, Inc. | FWBI – First Wave BioPharma, Inc. |
| GALT – Galectin Therapeutics Inc. | GHSI – Guardion Health Sciences, Inc. |
| GLMD – Galmed Pharmaceuticals Ltd. |
Financial data and stock pages provided by
Fintel.io